<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03955081</url>
  </required_header>
  <id_info>
    <org_study_id>2018-GI (OEKG) - 01</org_study_id>
    <nct_id>NCT03955081</nct_id>
  </id_info>
  <brief_title>A Clinical Study With the Medical Device PowerSpiral for Deep Enteroscopy</brief_title>
  <acronym>SAMISEN</acronym>
  <official_title>Safety and Performance of the Motorized Spiral Endoscope (PowerSpiral) in Subjects Indicated for Small-bowel Enteroscopy: A PMCF Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Olympus Europe SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Olympus Europe SE &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the SAMISEN study is to assess the performance and safety of diagnostic and
      therapeutic procedures with the newly designed Olympus Motorized Spiral Enteroscope
      (PowerSpiral).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective of this registry is to collect data on the safety and performance of the
      new motorized PowerSpiral device during Post-market Clinical Follow-up. It is assumed that
      the new device and its safety profile is non-inferior to preceding generations of balloon
      assisted enteroscopes.

      As clinical performance and efficacy is equally important for the user this study also
      collects efficacy and handling data of the new device.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Days</target_duration>
  <primary_outcome>
    <measure>Collect Serious Adverse Events and Device Deficiencies to demonstrate safety of the Motorized Spiral Endoscope (PowerSpiral) in daily medical practice.</measure>
    <time_frame>up to 12 days</time_frame>
    <description>It is assumed that the new device and its safety profile is non-inferior to preceding generations of balloon assisted enteroscopes. Endoscope (PowerSpiral) in a typical clinical setting within the Intended Use</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diagnostic Yield</measure>
    <time_frame>up to 12 days</time_frame>
    <description>Defined as the percentage of procedures that either confirmed a diagnosis from previous studies, or established a new definitive diagnosis at the anatomical location identified in previous studies or findings that could explain the clinical symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Therapeutic Yield</measure>
    <time_frame>up to 12 days</time_frame>
    <description>Defined as the percentage of patients with any endoscopic intervention / therapy with the exception of biopsies.</description>
  </primary_outcome>
  <enrollment type="Anticipated">335</enrollment>
  <condition>Small Bowel Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep enteroscopy</intervention_name>
    <description>A deep enteroscopy conducted with the new medical device PowerSpiral.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with an indication for direct visualization of the small bowel which fulfil all of
        these inclusion and exclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Signed informed consent

          2. Patients with small bowel disease indicated for deep enteroscopy

        Exclusion Criteria:

          1. Age under 18 years

          2. Female and of child-bearing age who is currently pregnant or planning to become
             pregnant within the study period

          3. Any contraindication to standard enteroscopy

          4. Concurrent participation in another competing clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Torsten Beyna, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Evangelisches Kranken-haus Düssel-dorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter Teichmann, PhD</last_name>
    <phone>+49 40 23773-0</phone>
    <phone_ext>-7835</phone_ext>
    <email>peter.teichmann@olympus-europa.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Erasme,</name>
      <address>
        <city>Brussels</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NA NA</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cliniques universitaires Saint-Luc ASBL</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NA NA</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus N</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NA NA</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NA NA</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon, Hôpital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NA NA</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Düsseldorf</name>
      <address>
        <city>Duesseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Torsten Beyna, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NA NA</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum rechts der Isar</name>
      <address>
        <city>Münich</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NA NA</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sana Klinikum Offenbach GmbH</name>
      <address>
        <city>Offenbach</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Università Cattolica del Sacro Cuore</name>
      <address>
        <city>Rom</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University Division of Gastroenterology</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Amsterdam UMC Universitair Medische Centre</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>OUS-Rikshospitalet University Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NA NA</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Norway</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>February 1, 2019</study_first_submitted>
  <study_first_submitted_qc>May 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2019</study_first_posted>
  <last_update_submitted>May 15, 2020</last_update_submitted>
  <last_update_submitted_qc>May 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

